Michael Brainin (born 24 May 1951) is an Austrian neurologist and emeritus professor at the Danube University Krems.
[2] In 1994 Brainin was appointed chairman of the neurological department at the Gugging Hospital where, in 1997, he founded the first acute stroke unit in Austria.
From 2007 he moved as chair and professor to the neurological department of the newly founded University Hospital Tulln.
[3] Until his retirement from hospital work in 2016 he was Principle Co-Investigator of numerous international studies on new treatments for stroke, including thrombolysis and neuroprotection.
In 2005 he was appointed full professor and chairman of the Department for Clinical Neurosciences and Preventive Medicine where he remained until his retirement in 2020.
[12] In 2017, Brainin received the Science Award of the State of Lower Austria,[2] the Marinescu Award of the Romanian Society for Neurology (2015),[2] honorary doctorates from the universities of Iuliu Hațieganu[13] (Romania) and Hanoi[14] (Vietnam), as well an honorary professorship at Zhengzhou University[14] in China.
Brainin is also an honorary member of the Austrian Stroke Society and has been awarded with the annual Hans Chiari Lecture in 2022.
In 2021, Brainin received the Presidential Award from the European Stroke Organization (ESO), the Ring of Honor[1] from the Danube University Krems, and the Silver Commander's Cross for Services to the State of Lower Austria.